MedPath

Tear Osmolarity Over Time With Artificial Tears

Phase 4
Conditions
Dry Eye
Interventions
Drug: Artificial tears
Registration Number
NCT01227226
Lead Sponsor
Hom, Milton M., OD, FAAO
Brief Summary

The effect of artificial tears on tear osmolarity

Detailed Description

Tear osmolarity measures the amount of solutes in the human tear film. The higher the reading, the more likely the patient has dry eyes. Some say it has "potential to be the gold standard" of dry eye testing. The investigators study the tear osmolarity at different time points after instillation of artificial tears.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
48
Inclusion Criteria

Between the ages of 18 and over inclusive. Males or females Any race or ethnic background Patient is in generally good & stable overall health. Patient likely to comply with study guidelines & study visits. Informed consent signed. Subjective evaluation of symptom of dryness (SESoD): Score 2 (Mild)

Exclusion Criteria

Corneal refractive surgery within 6 months of this study. Intra-ocular surgery within 6 months or ocular laser surgery within 6 months. Pregnant or lactating women. Ocular pathology (includes glaucoma and cataract), which could impact results and/or place patient at risk.

Corneal staining Grade 3 or higher No Restasis for past 3 months Discontinue topical medications for at least 1 week

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Refresh tearsArtificial tearsAllergan's Refresh tears artificial tear
Systane UltraArtificial tearsAlcon's Systane Ultra artificial tear
VisineArtificial tearsVisine artificial tear
Blink tearsArtificial tearsAMO's blink tears artificial tear
Primary Outcome Measures
NameTimeMethod
Tear osmolarity2 days

Tear osmolarity measured with TearLab instrument

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Milton M. Hom, OD, FAAO.

🇺🇸

Azusa, California, United States

© Copyright 2025. All Rights Reserved by MedPath